Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis Yasuda T; Ishida T; Rader DJCirc J 2010[Nov]; 74 (11): 2263-70Endothelial lipase (EL) is a phospholipase that belongs to the lipoprotein lipase (LPL) family, which includes LPL and hepatic lipase (HL). Similar to LPL and HL, EL regulates lipoprotein metabolism, mainly high-density lipoprotein (HDL) metabolism and HDL cholesterol (HDL-C) levels in humans and mice. Existing data strongly suggest that inhibition of EL in humans would be expected to increase the HDL-C level. However, it has not been definitively established whether the effect of EL activity on HDL-C levels translates into effects on reverse cholesterol transport or atherosclerosis. The available data regarding the impact of EL expression and activity on HDL metabolism, reverse cholesterol transport, and atherosclerosis are reviewed.|Animals[MESH]|Atherosclerosis/drug therapy/*enzymology/genetics[MESH]|Biological Transport[MESH]|Cardiovascular Agents/pharmacology[MESH]|Cholesterol/*metabolism[MESH]|Endothelium, Vascular/drug effects/*enzymology[MESH]|Enzyme Inhibitors/pharmacology[MESH]|Humans[MESH]|Lipase/antagonists & inhibitors/genetics/*metabolism[MESH]|Lipoproteins, HDL/*metabolism[MESH]|Mice[MESH]|Polymorphism, Single Nucleotide[MESH] |
